YONGHE MED.GR.DL-0000025 (F:L97) — Stock Price
YONGHE MED.GR.DL-0000025 (F:L97) is currently trading at €0.25 EUR, down 3.79% today. Over the past 52 weeks, shares have ranged between €0.17 and €0.33. This page tracks YONGHE MED.GR.DL-0000025's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see YONGHE MED.GR.DL-0000025 market capitalisation.
YONGHE MED.GR.DL-0000025 (L97) Stock Price Chart — Daily History & Trading Volume
The chart below tracks YONGHE MED.GR.DL-0000025's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
YONGHE MED.GR.DL-0000025 Income Statement — Revenue, Profit & Earnings by Year
YONGHE MED.GR.DL-0000025's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €1.81 Billion | €1.80 Billion | €1.78 Billion | €1.41 Billion | €2.17 Billion |
| Cost of Revenue | €614.10 Million | €720.29 Million | €780.07 Million | €540.21 Million | €588.60 Million |
| Gross Profit | €1.19 Billion | €1.08 Billion | €997.19 Million | €872.58 Million | €1.58 Billion |
| Research & Development | €19.26 Million | €21.25 Million | €29.28 Million | €18.50 Million | €14.16 Million |
| SG&A | €611.98 Million | €702.04 Million | €833.20 Million | €566.76 Million | €818.00 Million |
| Total Operating Expenses | €1.68 Billion | €1.93 Billion | €2.23 Billion | €1.57 Billion | €1.92 Billion |
| Operating Income | €131.73 Million | €-124.69 Million | €-450.79 Million | €-160.54 Million | €249.23 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €23.03 Million | €41.22 Million | €54.16 Million | €51.23 Million | €51.95 Million |
| Income Before Tax | €105.45 Million | €-255.29 Million | €-585.22 Million | €-109.47 Million | €210.28 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €73.71 Million | €-226.34 Million | €-546.39 Million | €-85.86 Million | €120.19 Million |
YONGHE MED.GR.DL-0000025 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes YONGHE MED.GR.DL-0000025's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €1.70 Billion | €1.73 Billion | €2.44 Billion | €2.93 Billion | €3.20 Billion |
| Total Current Assets | €853.50 Million | €629.82 Million | €809.33 Million | €1.19 Billion | €1.75 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €50.18 Million | — | — | €412.94 Million | — |
| Net Receivables | €9.81 Million | €4.63 Million | €10.27 Million | €7.05 Million | €13.35 Million |
| Inventory | €13.30 Million | €40.53 Million | €76.00 Million | €88.09 Million | €53.14 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €0.00 | €0.00 | €10.32 Million | €25.16 Million | €25.16 Million |
| Total Liabilities | €914.47 Million | €1.01 Billion | €1.50 Billion | €1.35 Billion | €1.50 Billion |
| Total Current Liabilities | €549.30 Million | €545.71 Million | €722.90 Million | €498.51 Million | €737.68 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €788.05 Million | €714.34 Million | €942.56 Million | €1.59 Billion | €1.70 Billion |
| Retained Earnings | €-522.47 Million | €-596.18 Million | €-369.83 Million | €176.56 Million | €302.48 Million |
YONGHE MED.GR.DL-0000025 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how YONGHE MED.GR.DL-0000025 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €495.53 Million | €228.62 Million | €-17.15 Million | €-108.56 Million | €437.28 Million |
| Capital Expenditures | €18.90 Million | €53.76 Million | €171.31 Million | €243.51 Million | €190.64 Million |
| Free Cash Flow | €476.63 Million | €174.85 Million | €-188.47 Million | €-352.07 Million | €246.64 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | €43.16 Million | €69.80 Million |
| Stock-Based Compensation | €58.00K | €113.00K | €184.00K | €184.00K | €184.00K |
| Depreciation | €243.68 Million | €315.21 Million | €334.84 Million | €224.67 Million | €200.97 Million |
| Change in Cash | €211.35 Million | €-115.36 Million | €43.23 Million | €-1.09 Billion | €1.27 Billion |
YONGHE MED.GR.DL-0000025 Earnings History — EPS Actual vs. Analyst Estimates
Track YONGHE MED.GR.DL-0000025's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for YONGHE MED.GR.DL-0000025.